Clinical Trials Logo

Clinical Trial Summary

Patients with neurodevelopmental diseases and their families need to identify the genetic cause of the disease to allow for recognition of the disability, genetic counseling, and possible hope for participation in therapeutic research studies. Access to high-throughput genomic exome or genome analysis allows the identification of a genetic cause for approximately half of the patients. However, families with no result or with a variant of unknown significance after these tests may find themselves in a new diagnostic impasse. The high-throughput sequencing used today generates sequences of the order of 100 base pairs (so-called "short read" sequencing). This allows an analysis of about 90% of the genome. However, many regions are not accessible in regions of interest for the genetic diagnosis of rare diseases. Long fragment sequencing generates sequences that are about 20 times larger and its use has recently made it possible to sequence the human genome almost completely (https://www.science.org/doi/10.1126/science.abj6987). The main contribution lies in the analysis of complex regions of the genome such as segmental duplications or centromeric regions. It is likely that this technology increases the sensitivity of detection of genetic variants in patients with genetic diseases. Its contribution should be studied in patients for whom no genetic cause has been identified by classical techniques. This study aim to investigate the contribution of long fragment genome sequencing.


Clinical Trial Description

Ten families with a child suffering from a neurodevelopmental disease will be recruited by geneticists being part of the CLAD-Ouest. An EDTA blood sample will be taken from the patient and their parents (trio analysis). The blood samples will then be used to extract nucleic acids (DNA). The blood samples will be sent and centralized to the genetics laboratory of the Nantes University Hospital. The DNA will be extracted and anonymized. The files generated after DNA sequencing will have as an identification key the anonymization number provided at the time of inclusion of the individual in the study. The raw data and VCF files will be uploaded to the BIRD computing cluster in Nantes, where they will be stored for the duration of the study (2 years). The different university hospitals will then be able to retrieve the data and analyze the variants identified in the patients recruited by their center. A centralized analysis to annotate, filter and interpret the variants will be performed by a group of bioinformaticians and biologists from HUGO (University Hospital from the Grand Ouest). Long-term archiving of the data will be performed at the Nantes University Hospital. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05643274
Study type Observational
Source Nantes University Hospital
Contact
Status Completed
Phase
Start date December 19, 2022
Completion date March 8, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05519592 - Proximal Lower Limb Intramuscular Block : Effects on Hemiparetic Gait N/A
Recruiting NCT04098679 - Childhood Adiposity and Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes (CONCEPTT Kids)
Completed NCT03946137 - Chest Therapy and Postural Education in Children With Cerebral Palsy N/A
Completed NCT05217186 - Associations Between Early Neonatal Neuroimaging, Hammersmith Infant Neurological Examination and General Movements
Not yet recruiting NCT05506306 - Multitissular Effect of Vertical Mobilization Using the Exoskeleton AtalanteTM in Neurological Chair- or Bed-bound Patients
Recruiting NCT04846413 - Voice Analysis in Patients With Neurologic Diseases
Recruiting NCT05260190 - Manual Dexterity Modifications After Application of tSMS Over the Primary Motor Cortex (M1) N/A
Not yet recruiting NCT04906681 - Implementation of a Rehabilitation Technology in Orthopedic and Neurological Rehabilitation to Increase Therapy Dosage: an Exploratory Study Phase 1/Phase 2
Completed NCT04743037 - Interactive Self-Management Augmented by Rehabilitation Technologies N/A
Not yet recruiting NCT03899298 - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions Phase 1
Active, not recruiting NCT04631965 - Healthcare Transition of Adolescents With Chronic Health Conditions
Recruiting NCT05132517 - Magnesium and Cognition After Stroke
Recruiting NCT04100993 - Multisystem and Autonomic Complications of NMD on Long-term NIV
Recruiting NCT05652946 - IISART (International Industry Society of Advanced Rehabilitation Technology) Advanced Rehabilitation Technology Study N/A
Recruiting NCT06146543 - Stress Ball During Lumbar Puncture the Effect of the Application on Anxiety Level N/A
Completed NCT06368024 - Establishment of Delphi-MD Safety Performance and Reliability
Not yet recruiting NCT06169696 - EMPOWER Early Feasibility Study: Non-invasive BCI to Control a Wheelchair for People With Paralysis N/A
Completed NCT03329872 - Neuro-Orthopedic Registry of the University Hospital of Toulouse
Completed NCT05483244 - Weaning Success in Different Weaning Strategies in Early Neurological Rehabilitation Patients - a Matched-pair Analysis
Completed NCT04170985 - NeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Whole Genome Sequencing (WGS) in Adult Neurology